Guanine Inc
Guanine Inc. develops advanced electrochemical biosensors, specifically the eOligo biosensor, which enables rapid, affordable, and multiplexed detection of low-concentration biomarkers in blood. Their technology aims to revolutionize diagnostics and precision health by providing real-time, high-sensitivity testing for diseases such as cancer, infections, and neurodegenerative conditions, facilitating faster decision-making and AI integration.
Industries
Nr. of Employees
small (1-50)
Guanine Inc
7 University Place, Suite B210, Rensselaer, NY 12144-3463
Products
Electrochemical oligonucleotide (eOligo) biosensor platform
A platform that uses high-density electroactive oligonucleotide tags and electrochemical detection on disposable cartridges and a mobile reader to quantify multiple low-abundance biomarkers (nucleic acids, proteins, small molecules, cells, redox targets) from blood samples.
Point-of-care sepsis diagnostic (upcoming)
Planned rapid test intended to return pathogen identity, resistance genes and antibiotic MIC estimates within approximately one hour for use in emergency settings to guide antibiotic selection.
Electrochemical oligonucleotide (eOligo) biosensor platform
A platform that uses high-density electroactive oligonucleotide tags and electrochemical detection on disposable cartridges and a mobile reader to quantify multiple low-abundance biomarkers (nucleic acids, proteins, small molecules, cells, redox targets) from blood samples.
Point-of-care sepsis diagnostic (upcoming)
Planned rapid test intended to return pathogen identity, resistance genes and antibiotic MIC estimates within approximately one hour for use in emergency settings to guide antibiotic selection.
Services
Developer toolkit to enable assay design, prototyping and migration onto a mobile cartridge-based electrochemical diagnostic platform; intended for external assay developers.
Developer toolkit to enable assay design, prototyping and migration onto a mobile cartridge-based electrochemical diagnostic platform; intended for external assay developers.
Expertise Areas
- Electrochemical biosensing
- Multiplexed diagnostics
- Point-of-care infectious disease diagnostics
- Antimicrobial resistance detection and rapid AST
Key Technologies
- Electrochemical oligonucleotide tagging
- Multiplexed electrochemical detection
- Magnetic separation for pathogen capture
- Large-volume filtration for sample concentration
News & Updates
A publication by Gordon, N., Bawa, R., Palmateer, G. in Engineering Proceedings (2023), discussing the detection of pathogens and resistance genes using electrochemical oligonucleotide tags.
A chapter in Advances in Medical Imaging, Detection, and Diagnosis (2023) by Gordon, N., Bawa, R., Palmateer, G., et al., on rapid testing for resistant bacteria.
Bioanalyte Signal Amplification and Detection with Artificial Intelligence Diagnosis.
Ultra-Sensitive Bioanalyte Quantification from Self-Assembled Quadruplex Tags.
A publication by Gordon, N., Bawa, R., Palmateer, G. in Engineering Proceedings (2023), discussing the detection of pathogens and resistance genes using electrochemical oligonucleotide tags.
A chapter in Advances in Medical Imaging, Detection, and Diagnosis (2023) by Gordon, N., Bawa, R., Palmateer, G., et al., on rapid testing for resistant bacteria.
Bioanalyte Signal Amplification and Detection with Artificial Intelligence Diagnosis.
Ultra-Sensitive Bioanalyte Quantification from Self-Assembled Quadruplex Tags.